A synthesis of 47 recently added cannabis articles — key themes, clinical context, and Dr. Caplan’s take.
Study reveals cannabis compounds reduce threat of fatty liver disease | Health
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchCBDTHCAging Why This Matters This research identifying specific cannabis compounds that may reduce hepatic steatosis...
Israeli researchers find cannabis compounds could lead to 1st drug for fatty liver disease
✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchCBDTHC Why This Matters This research is clinically significant because nonalcoholic fatty liver disease (NAFLD)...
Cannabis Compounds Exhibit Potential in Combatting Fatty Liver Disease
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchCBDTHCAging Why This Matters Clinicians managing patients with fatty liver disease now have preliminary evidence...